Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid-refractory Acute Graft-versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03491215
What this trial is testing

Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease

Who this might be right for
Acute Graft Versus Host Disease
Novartis Pharmaceuticals 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06075225
What this trial is testing

MAP-guided Preemptive Therapy of aGvHD by Ruxolitinib

Who this might be right for
GVHDAcute Stem Cell Transplant Complications
Sichuan University 62
Testing effectiveness (Phase 2)Ended earlyNCT02993783
What this trial is testing

A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Millennium Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Ended earlyNCT01903473
What this trial is testing

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Chronic Graft-Versus-Host DiseaseAcute Graft-Versus-Host DiseaseSteroid Refractory Graft-Versus-Host Disease
University of Liege 19
Large-scale testing (Phase 3)UnknownNCT04289103
What this trial is testing

Evaluation of EFficacy and SaFEty of Leukotac (Inolimomab) in Pediatric Patients With SR-aGvHD

Who this might be right for
Steroid Refractory GVHD
ElsaLys Biotech 65
Testing effectiveness (Phase 2)WithdrawnNCT02694770
What this trial is testing

A Study Evaluating the Efficacy and Safety of Neihulizumab vs "Conventional Treatment" to Treat Sr-aGvHD

Who this might be right for
Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation
AbGenomics B.V Taiwan Branch
Testing effectiveness (Phase 2)Ended earlyNCT00409695
What this trial is testing

Thymoglobulin (ATG) Dose Finding Study

Who this might be right for
Graft vs Host Disease
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)UnknownNCT05368181
What this trial is testing

MAP-guided Preemptive Therapy of aGvHD

Who this might be right for
GVHD,AcuteStem Cell Transplant Complications
Sichuan University 56
Testing effectiveness (Phase 2)Looking for participantsNCT07708987
What this trial is testing

Study of Standardized Withaferin-A for the Treatment of Steroid Refractory Acute Graft Versus Host Disease.

Who this might be right for
Hematological MalignancyGVHD - Graft-Versus-Host DiseaseSteriod Refractory
Tata Memorial Centre 34
Testing effectiveness (Phase 2)Study completedNCT02027805
What this trial is testing

Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD

Who this might be right for
Graft vs Host Disease
Xenikos 20
Large-scale testing (Phase 3)Looking for participantsNCT04629833
What this trial is testing

Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy

Who this might be right for
Steroid-refractory Acute Graft-versus-host Disease
medac GmbH 210
Early research (Phase 1)Ended earlyNCT04227938
What this trial is testing

ALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHD

Who this might be right for
Graft Vs Host Disease
Alpine Immune Sciences, Inc. 1
Testing effectiveness (Phase 2)WithdrawnNCT00578591
What this trial is testing

Rituximab for GVHD

Who this might be right for
Graft vs Host DiseaseAlogenic Hematopoietic Transplant
Baylor College of Medicine
Testing effectiveness (Phase 2)UnknownNCT01549665
What this trial is testing

Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease

Who this might be right for
Graft-Versus-Host DiseaseGVHDAllogeneic Hematopoietic Transplant+1 more
Samsung Medical Center 30
Early research (Phase 1)Ended earlyNCT02436460
What this trial is testing

AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant

Who this might be right for
Acute Graft Versus Host Disease
AbGenomics B.V Taiwan Branch 4
Testing effectiveness (Phase 2)Study completedNCT02824653
What this trial is testing

Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD

Who this might be right for
Graft Versus Host Disease
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 10
Testing effectiveness (Phase 2)Ended earlyNCT01530256
What this trial is testing

Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD)

Who this might be right for
Acute GvHD
CSL Behring 3
Testing effectiveness (Phase 2)Looking for participantsNCT07572669
What this trial is testing

Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Steroid-Refractory Acute Graft-Versus-Host DiseaseAcute Graft-Versus-Host DiseaseGraft-Versus-Host Disease+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 42
Testing effectiveness (Phase 2)Looking for participantsNCT07364617
What this trial is testing

Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD

Who this might be right for
Graft vs Host Disease
Chang Gung Memorial Hospital 35
Testing effectiveness (Phase 2)Ended earlyNCT00038792
What this trial is testing

Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD

Who this might be right for
Acute Graft Versus Host Disease
M.D. Anderson Cancer Center 7
Next Page